Brain metastases and steroid reduction after radiotherapy [3]

Palliative Medicine

Volumn 18, Issue 7, 2004, Pages 665-666

  Thomson, A H ^a   Tomlinson, M J ^b  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

BRAIN EDEMA; BRAIN METASTASIS; BREAST CANCER; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ESOPHAGUS CANCER; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MELANOMA; PROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 7944227457     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921630401800715     Document Type: Letter

References (6)

1. Hempen C, Weiss E, Hess CF. Dexamethasone treatment in patients with brain metastases and primary brain tumours: do the benefits outweigh the side effects? Support Care Cancer 2002; 10: 322-28.
2. Tsao MN, Sulanem K, Chiu D, Copps F, Dixon P, Easton D, Haddad P, Hayter C, Hoegler D, Wong R. Supportive care management of brain metastases: what is known and what we need to know. Clin Oncol 2003; 15: 429-34.
3. Weissman DE, Janjan NA, Erickson B, et al. Twice daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. J Neurooncol 1991; 11: 235-39.
4. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996; 8: 308-15.
5. Eaker S, Bergstrom R, Bergstrom A, Adami HO, Nyren O. Response rate to mailed epidemiologic questionnaires: a population based randomised trial of variations in design and mailing routes. Am J Epidemiol 1998; 147: 74-82.
6. Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national initiative. J Am Pharm Assoc (Wash DC). 2003; 43: 665.